Prelude Trust
25
8M
13
1.04
3
0.48
6
- Stages of investment
- Areas of investment
Summary
Prelude Trust is the famous VC, which was founded in 1997. The company was established in Europe in United Kingdom. The main office of represented VC is situated in the London.
The important activity for fund was in 2006. The common things for fund are deals in the range of 5 - 10 millions dollars. The real fund results show that this VC is 5 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. This Prelude Trust works on 6 percentage points less the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2016.
The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight XMOS, m-spatial, ZBD Displays. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Prelude Trust, startups are often financed by DSM Venturing, BASF Venture Capital, TTP Ventures. The meaningful sponsors for the fund in investment in the same round are TTP Ventures, The Dow Chemical Company, DSM Venturing. In the next rounds fund is usually obtained by TTP Ventures, Bioventures Investors, Wellington Partners.
Investments analytics
Analytics
- Total investments
- 25
- Lead investments
- 3
- Exits
- 6
- Rounds per year
- 1.04
- Follow on index
- 0.48
- Investments by industry
- Software (10)
- Semiconductor (8)
- Manufacturing (5)
- Health Care (4)
- Biotechnology (4) Show 24 more
- Investments by region
-
- United Kingdom (18)
- United States (5)
- Netherlands (2)
- Peak activity year
- 2006
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 57M
- Group Appearance index
- 0.96
- Avg. company exit year
- 12
- Avg. multiplicator
- 2.90
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Oxford Immunotec | 10 Aug 2005 | Biotechnology, Health Care, Health Diagnostics | Early Stage Venture | 9M | England, Vale of White Horse, United Kingdom |
| Polatis | 11 Nov 2004 | Software, Information Technology, Manufacturing, Consumer Electronics, Web Hosting, Optical Communication | Late Stage Venture | 9M | United States, Massachusetts |
| Thematic | 25 Jan 2022 | Marketplace, Content, Music, Audio, Independent Music, Content Delivery Network, Customer Service, Text Analytics, Content Creators, Content Marketing, Consumer Reviews | Seed | United States, California |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.